Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India

Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India

PURPOSEBiliary tract cancers (BTCs) are usually diagnosed in advanced stages, where treatment options are either palliative chemotherapy and/or best supportive care. The breakthrough results of the TOPAZ-1 trial demonstrated a 24% decrease in risk of death at 2 years with the addition of durvalumab...

Full description

Bibliographic Details
Main Authors: Vamshi Krishna Muddu, Anjali Shah, Anupa John, Abhishek Raj, Ankur Bahl, Senthil J. Rajappa, Thirumalairaj Raja, Joydeep Ghosh, Viraj Lavingia, Amish Vora, Prabhat Bhargava, Anant Ramaswamy, Arif Khan, Atul Sharma, Mehak Trikha, Aditya Dhanawat, Avinash Bonda, Indraja Siripurapu, Manoj Mahajan, Nitesh Rohatgi, Mosale Venkatesha Chandrakant, Himanshu Gujarathi, Manan Vora, Sumankumar Ankathi, Vikas S. Ostwal
Format: Article
Language:English
Published: American Society of Clinical Oncology 2024-12-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO.24.00216

Internet

https://ascopubs.org/doi/10.1200/GO.24.00216

Similar Items